These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36301435)

  • 1. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
    Webb M; Johnson DR; Mahajan A; Brown P; Neth B; Kizilbash SH; Sener U
    J Neurooncol; 2022 Nov; 160(2):527-534. PubMed ID: 36301435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series.
    Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR
    World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
    Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
    Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
    World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
    Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
    Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pineal parenchymal tumor of intermediate differentiation: a single-institution experience.
    Nam JY; Gilbert A; Cachia D; Mandel J; Fuller GN; Penas-Prado M; de Groot J; Kamiya-Matsuoka C
    Neurooncol Pract; 2020 Dec; 7(6):613-619. PubMed ID: 33312675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
    Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
    Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.
    Takase H; Tanoshima R; Singla N; Nakamura Y; Yamamoto T
    Neurosurg Rev; 2022 Apr; 45(2):1135-1155. PubMed ID: 34668090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis.
    Mallick S; Benson R; Rath GK
    Radiother Oncol; 2016 Nov; 121(2):204-208. PubMed ID: 27865543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
    Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S;
    J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation therapy for pineal parenchymal tumor of intermediate differentiation: A case series and literature review.
    Liu C; Carmicheal J; Baine MJ; Zhang C
    J Cent Nerv Syst Dis; 2023; 15():11795735231160036. PubMed ID: 36949932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spinal Dissemination of Pineal Parenchymal Tumors of Intermediate Differentiation Over 10 Years After Initial Treatment: A Case Report.
    Miyazaki A; Makino K; Shinojima N; Yamashita S; Mikami Y; Mukasa A
    Cureus; 2024 Mar; 16(3):e57147. PubMed ID: 38681294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant Pineal Parenchymal Tumors in Adults: A National Cancer Database Analysis.
    Chalif EJ; Murray RD; Mozaffari K; Chillakuru YR; Shim T; Monfared A; Sherman JH
    Neurosurgery; 2022 Jun; 90(6):807-815. PubMed ID: 35311743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
    Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
    Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Twenty-seven cases of pineal parenchymal tumours of intermediate differentiation: mitotic count, Ki-67 labelling index and extent of resection predict prognosis.
    Yu T; Sun X; Wang J; Ren X; Lin N; Lin S
    J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):386-95. PubMed ID: 25911570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term outcome of adolescent and adult patients with pineal parenchymal tumors treated with fractionated radiotherapy between 1982 and 2003--a single institution's experience.
    Stoiber EM; Schaible B; Herfarth K; Schulz-Ertner D; Huber PE; Debus J; Oertel S
    Radiat Oncol; 2010 Dec; 5():122. PubMed ID: 21184689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) and Papillary Tumor of Pineal Region (PTPR): A Review.
    Sadashiva N; Deora H; Arumalla K; Rao S; Saini J; Shukla D; Santosh V
    Neurol India; 2021; 69(5):1153-1164. PubMed ID: 34747779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic Prognostic Factors of Pineal Parenchymal Tumor of Intermediate Differentiation.
    Chatterjee D; Lath K; Singla N; Kumar N; Radotra BD
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):210-215. PubMed ID: 28800009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pineal parenchymal tumors. Clinical, pathologic, and therapeutic aspects.
    Schild SE; Scheithauer BW; Schomberg PJ; Hook CC; Kelly PJ; Frick L; Robinow JS; Buskirk SJ
    Cancer; 1993 Aug; 72(3):870-80. PubMed ID: 8334641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
    Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
    Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.